Katsuyuki Okubo

USPTO Granted Patents = 15 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 16)

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 108(Granted Patents)

Company Filing History:

14 out of 3,871

Nitto-denko Corporation

Toray Industries, Inc.

patents

where one patent can have more than one assignee

Years Active: 1980-2020

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10744197 - Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration (2020-08-18),

2. 10722570 - Dried influenza vaccine preparation and method for producing dried influenza vaccine preparation (2020-07-28),

3. 10688120 - Allergy vaccine composition (2020-06-23),

4. 10449144 - WT1 peptide cancer vaccine composition for transdermal administration (2019-10-22),

5. 10420837 - Vaccine pharmaceutical composition for transdermal administration (2019-09-24),

6. 10391167 - Mucosal vaccine composition (2019-08-27),

7. 10206985 - WT1 peptide cancer vaccine composition for mucosal administration (2019-02-19),

8. 10195258 - Tape preparation of WT1 peptide cancer vaccine for transdermal administration (2019-02-05),

9. 10092642 - Mucosal vaccine composition (2018-10-09),

10. 10076491 - Vaccine composition (2018-09-18),

11. 10071155 - Nasal mucosal vaccine composition (2018-09-11),

12. 10071051 - WT1 peptide cancer vaccine composition for transdermal administration (2018-09-11),

13. 9962439 - Injectable vaccine composition (2018-05-08),

14. 7442682 - Transepithelial delivery of peptides with incretin hormone activities (2008-10-28),

15. 4193474 - Sound insulating unit and sound barrier (1980-03-18),

Title: Katsuyuki Okubo: Innovator in Vaccine Development

Introduction

Katsuyuki Okubo is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of vaccine development, holding a total of 15 patents. His work focuses on creating innovative pharmaceutical compositions that enhance the stability and efficacy of vaccines.

Latest Patents

Okubo's latest patents include a vaccine pharmaceutical composition for oral administration and a method for manufacturing this composition. This invention provides a stable vaccine formulation that allows for the oral delivery of an influenza virus antigen, ensuring its effective storage. Additionally, he has developed a dried influenza vaccine preparation that maintains the vaccine's activity even under less stringent temperature conditions. This preparation includes an influenza vaccine antigen, a disaccharide, and an amino acid, making it a significant advancement in vaccine technology.

Career Highlights

Throughout his career, Katsuyuki Okubo has worked with notable organizations such as Nitto Denko Corporation and Osaka University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in vaccine development.

Collaborations

Some of his notable coworkers include Daisuke Asari and Mitsuhiko Hori. Their collaborative efforts have furthered advancements in the pharmaceutical industry, particularly in vaccine research.

Conclusion

Katsuyuki Okubo's innovative work in vaccine development has made a lasting impact on public health. His contributions continue to pave the way for more effective and stable vaccine formulations.

This text is generated by artificial intelligence and may not be accurate.